AptarGroup, Inc. develops drug delivery and consumer-product dosing, dispensing and protection technologies for pharmaceutical, beauty, food, beverage, personal care and home care markets. News about ATR commonly covers operating results across Pharma, Beauty and Closures, demand trends in prescription drug delivery, biologics, injectables, nasal delivery, fragrance dispensing and closure applications.
Company updates also include product introductions such as inverted lidless dispensing closures using SimpliSqueeze® valve technology, Aptar Pharma delivery systems used in clinical-stage nasal therapies, Aptar Digital Health partnerships, dividend declarations, share repurchases and investor presentations.
AptarGroup, Inc. (NYSE: ATR) has declared a quarterly cash dividend of $0.36 per share, payable on February 17, 2021, to stockholders of record as of January 27, 2021. The company will also hold a conference call on February 19, 2021, at 8:00 a.m. Central Time to discuss its fourth quarter and year-end results for 2020. Additionally, the 2021 Annual Meeting of Stockholders will be held virtually on May 5, 2021, at 9:00 a.m. Central Time, with a record date for voting set for March 12, 2021.
AptarGroup, Inc. (NYSE: ATR) will participate in the 39th Annual J.P. Morgan Healthcare Conference on January 14, 2021, with a virtual presentation at 2:50 p.m. (EST) by key executives including President and CEO Stephan Tanda. A live webcast will be available in the Investors section of the Aptar website and a replay will be accessible for 90 days post-event. Aptar is a global leader in drug delivery and packaging solutions, headquartered in Crystal Lake, Illinois, employing 14,000 people across 19 countries.
AptarGroup, Inc. (NYSE: ATR) has announced the schedule for its quarterly conference calls for 2021. Key dates include:
- 4th Quarter and Annual Results: February 18, 2021 (Call on February 19, 2021, at 8:00 a.m. CT)
- 1st Quarter 2021 Results: April 29, 2021 (Call on April 30, 2021, at 8:00 a.m. CT)
- 2nd Quarter 2021 Results: July 29, 2021 (Call on July 30, 2021, at 8:00 a.m. CT)
- 3rd Quarter 2021 Results: October 28, 2021 (Call on October 29, 2021, at 8:00 a.m. CT)
Press releases will be issued after the close of trading on NYSE.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
AptarGroup, Inc. (NYSE:ATR) reported a strong third quarter for 2020, with sales increasing by 8% to $759 million, driven by currency effects and recent acquisitions. The Pharma segment saw core sales growth of 11%, while Beauty + Home and Food + Beverage segments experienced slower growth, impacted by COVID-19. Reported earnings per share rose 12% to $0.95. Year-to-date sales were stable at $2.18 billion. The company anticipates continued core sales growth in Q4, expecting EPS between $0.84 and $0.92. A quarterly dividend of $0.36 per share was declared, payable November 18, 2020.
AptarGroup, Inc. (NYSE: ATR) has declared a quarterly cash dividend of $0.36 per share, with a payment date set for November 18, 2020 for shareholders on record as of October 28, 2020. Additionally, the company plans to hold a conference call on October 30, 2020, at 8:00 a.m. Central Time to discuss its third-quarter results for 2020. Investors can access a live webcast on the company's Investor Relations page.